Alisporivir

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAlisporivir
Drug Alias NameAlisporivirum阿拉泊韦阿珀利韦DEBIO-025DEB-025 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclophilin B inhibitorsCyclophilin A inhibitors
TargetsCyclophilin ACyclophilin B
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Chronic PainKidney Failure, Chronic +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[24] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesDebiopharm Group
China Registration ClassN/A

Develop Information

Active CompaniesRpscherer GermanyNovartis Pharma AgDebiopharm International Sa +[4] 
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Hepatitis C
Inactive IndicationsChronic PainKidney Failure, ChronicHepatic Insufficiency +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG